Please enable JavaScript to continue using this application.

Compare $PGEN vs $SLS | Chartloom

Compare

$PGEN vs $SLS

Precigen Inc · Sellas Life Sciences Group Inc

PGEN

Precigen Inc

SLS

Sellas Life Sciences Group Inc

Compare $PGEN vs $SLS

Comparing Precigen Inc and Sellas Life Sciences Group Inc

PGENPrecigen Inc

SLSSellas Life Sciences Group Inc

PGENPrecigen Inc

Market cap

$2.78B

P/E (TTM)

—

Forward P/E (NTM)

13.49x

Forward P/S (NTM)

8.46x

Rev growth (TTM)

1875.0%

YTD performance

82.5%

52W performance

142.5%

FCF yield

-4.1%

SLSSellas Life Sciences Group Inc

Market cap

$2.29B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

167.8%

52W performance

503.6%

FCF yield

-1.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PGEN

SLS

Detailed metrics comparison

PGEN

Precigen Inc

SLS

Sellas Life Sciences Group Inc

Market Cap

PGEN$2.78B

SLS$2.29B

Enterprise Value

PGEN$2.86B

SLS$2.15B

Price

PGEN$7.81

SLS$11.65

P/E Ratio

PGENN/A

SLSN/A

P/S Ratio

PGEN32.48x

SLS817.53x

EV/Sales

PGEN33.39x

SLS769.83x

EV/EBITDA

PGEN0.00x

SLS0.00x

P/B Ratio

PGEN70.17x

SLS17.22x

P/FCF Ratio

PGENN/A

SLSN/A

EV/FCF

PGEN-24.84x

SLS-75.73x

PEG Ratio

PGENN/A

SLSN/A

Forward P/E (NTM)

PGEN13.49x

SLSN/A

Forward P/S (NTM)

PGEN8.46x

SLSN/A

Revenue (TTM)

PGEN$86M

SLS$0

Revenue Growth (YoY)

PGEN1875.0%

SLSN/A

Forward Rev Growth

PGEN95.1%

SLS144.9%

Gross Margin (TTM)

PGEN90.7%

SLS93.1%

Operating Margin (TTM)

PGEN0.0%

SLS0.0%

EBITDA Margin (TTM)

PGEN-41.3%

SLS0.0%

Net Margin (TTM)

PGEN-392.8%

SLS0.0%

FCF Margin (TTM)

PGEN-134.4%

SLSN/A

Net Income (TTM)

PGEN$-337M

SLS$-32M

FCF (TTM)

PGEN$-115M

SLS$-28M

EPS (TTM)

PGEN-$0.81

SLS-$0.17

ROE (TTM)

PGEN-49832.0%

SLS-3591.0%

ROA (TTM)

PGEN-9923.0%

SLS-3334.0%

ROIC (TTM)

PGEN-12615.0%

SLS-3591.0%

Cash

PGEN$16M

SLS$138M

Debt

PGEN$94M

SLS$0

Net Cash/Debt

PGEN$-78M

SLS$138M

Current Ratio (TTM)

PGEN4.58x

SLS18.83x

Quick Ratio (TTM)

PGEN3.76x

SLS18.29x

Debt/Equity (TTM)

PGEN2.15x

SLS0.00x

Debt/Assets (TTM)

PGEN0.0%

SLS0.0%

Interest Coverage (TTM)

PGENN/A

SLSN/A

Net Debt/EBITDA (TTM)

PGEN0.00x

SLS0.00x

Beta

PGEN0.99

SLS2.68

52W Performance

PGEN142.5%

SLS503.6%

YTD Performance

PGEN82.5%

SLS167.8%

% from 52W High

PGEN-13.0%

SLS-26.6%

% from 52W Low

PGEN161.2%

SLS738.1%

Asset Turnover (TTM)

PGEN0.54x

SLS0.09x

FCF Yield (TTM)

PGEN-4.1%

SLS-1.2%

Earnings Yield (TTM)

PGEN-12.1%

SLS-1.4%

Dividend Yield (TTM)

PGENN/A

SLSN/A

Rule of 40

PGEN1,740.6

SLS0.0

EV/GP/RG

PGEN0.13

SLSN/A

Ticker research

View PGEN research View SLS research

Metric	PGEN Precigen Inc	SLS Sellas Life Sciences Group Inc
Market & Valuation
Market Cap	$2.78B	$2.29B
Enterprise Value	$2.86B	$2.15B
Price	$7.81	$11.65
P/E Ratio	N/A	N/A
P/S Ratio	32.48x	817.53x
EV/Sales	33.39x	769.83x
EV/EBITDA	0.00x	0.00x
P/B Ratio	70.17x	17.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-24.84x	-75.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	13.49x	N/A
Forward P/S (NTM)	8.46x	N/A
Revenue & Growth
Revenue (TTM)	$86M	$0
Revenue Growth (YoY)	1875.0%	N/A
Forward Rev Growth	95.1%	144.9%
Profitability
Gross Margin (TTM)	90.7%	93.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-41.3%	0.0%
Net Margin (TTM)	-392.8%	0.0%
FCF Margin (TTM)	-134.4%	N/A
Net Income (TTM)	$-337M	$-32M
FCF (TTM)	$-115M	$-28M
EPS (TTM)	-$0.81	-$0.17
ROE (TTM)	-49832.0%	-3591.0%
ROA (TTM)	-9923.0%	-3334.0%
ROIC (TTM)	-12615.0%	-3591.0%
Financial Health
Cash	$16M	$138M
Debt	$94M	$0
Net Cash/Debt	$-78M	$138M
Current Ratio (TTM)	4.58x	18.83x
Quick Ratio (TTM)	3.76x	18.29x
Debt/Equity (TTM)	2.15x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	2.68
52W Performance	142.5%	503.6%
YTD Performance	82.5%	167.8%
% from 52W High	-13.0%	-26.6%
% from 52W Low	161.2%	738.1%
Efficiency & Yields
Asset Turnover (TTM)	0.54x	0.09x
FCF Yield (TTM)	-4.1%	-1.2%
Earnings Yield (TTM)	-12.1%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,740.6	0.0
EV/GP/RG	0.13	N/A
Ticker research	View PGEN research	View SLS research

Valuation

P/S Ratio

PGEN

32.48x

SLS

817.53x

EV/FCF

SLS

-75.73x

PGEN

-24.84x

Growth & revenue

Revenue Growth TTM

PGEN

1875.0%

Forward Revenue Growth

SLS

144.9%

PGEN

95.1%

Profitability & performance

Gross Margin

SLS

93.1%

PGEN

90.7%

ROE

SLS

-3591.0%

PGEN

-49832.0%

FCF Yield %

SLS

-1.2%

PGEN

-4.1%

52-Week Performance

SLS

503.6%

PGEN

142.5%

Detailed metrics comparison

PGEN

Precigen Inc

SLS

Sellas Life Sciences Group Inc

Market Cap

PGEN$2.78B

SLS$2.29B

Enterprise Value

PGEN$2.86B

SLS$2.15B

Price

PGEN$7.81

SLS$11.65

P/E Ratio

PGENN/A

SLSN/A

P/S Ratio

PGEN32.48x

SLS817.53x

EV/Sales

PGEN33.39x

SLS769.83x

EV/EBITDA

PGEN0.00x

SLS0.00x

P/B Ratio

PGEN70.17x

SLS17.22x

P/FCF Ratio

PGENN/A

SLSN/A

EV/FCF

PGEN-24.84x

SLS-75.73x

PEG Ratio

PGENN/A

SLSN/A

Forward P/E (NTM)

PGEN13.49x

SLSN/A

Forward P/S (NTM)

PGEN8.46x

SLSN/A

Revenue (TTM)

PGEN$86M

SLS$0

Revenue Growth (YoY)

PGEN1875.0%

SLSN/A

Forward Rev Growth

PGEN95.1%

SLS144.9%

Gross Margin (TTM)

PGEN90.7%

SLS93.1%

Operating Margin (TTM)

PGEN0.0%

SLS0.0%

EBITDA Margin (TTM)

PGEN-41.3%

SLS0.0%

Net Margin (TTM)

PGEN-392.8%

SLS0.0%

FCF Margin (TTM)

PGEN-134.4%

SLSN/A

Net Income (TTM)

PGEN$-337M

SLS$-32M

FCF (TTM)

PGEN$-115M

SLS$-28M

EPS (TTM)

PGEN-$0.81

SLS-$0.17

ROE (TTM)

PGEN-49832.0%

SLS-3591.0%

ROA (TTM)

PGEN-9923.0%

SLS-3334.0%

ROIC (TTM)

PGEN-12615.0%

SLS-3591.0%

Cash

PGEN$16M

SLS$138M

Debt

PGEN$94M

SLS$0

Net Cash/Debt

PGEN$-78M

SLS$138M

Current Ratio (TTM)

PGEN4.58x

SLS18.83x

Quick Ratio (TTM)

PGEN3.76x

SLS18.29x

Debt/Equity (TTM)

PGEN2.15x

SLS0.00x

Debt/Assets (TTM)

PGEN0.0%

SLS0.0%

Interest Coverage (TTM)

PGENN/A

SLSN/A

Net Debt/EBITDA (TTM)

PGEN0.00x

SLS0.00x

Beta

PGEN0.99

SLS2.68

52W Performance

PGEN142.5%

SLS503.6%

YTD Performance

PGEN82.5%

SLS167.8%

% from 52W High

PGEN-13.0%

SLS-26.6%

% from 52W Low

PGEN161.2%

SLS738.1%

Asset Turnover (TTM)

PGEN0.54x

SLS0.09x

FCF Yield (TTM)

PGEN-4.1%

SLS-1.2%

Earnings Yield (TTM)

PGEN-12.1%

SLS-1.4%

Dividend Yield (TTM)

PGENN/A

SLSN/A

Rule of 40

PGEN1,740.6

SLS0.0

EV/GP/RG

PGEN0.13

SLSN/A

Ticker research

View PGEN research View SLS research

Metric	PGEN Precigen Inc	SLS Sellas Life Sciences Group Inc
Market & Valuation
Market Cap	$2.78B	$2.29B
Enterprise Value	$2.86B	$2.15B
Price	$7.81	$11.65
P/E Ratio	N/A	N/A
P/S Ratio	32.48x	817.53x
EV/Sales	33.39x	769.83x
EV/EBITDA	0.00x	0.00x
P/B Ratio	70.17x	17.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-24.84x	-75.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	13.49x	N/A
Forward P/S (NTM)	8.46x	N/A
Revenue & Growth
Revenue (TTM)	$86M	$0
Revenue Growth (YoY)	1875.0%	N/A
Forward Rev Growth	95.1%	144.9%
Profitability
Gross Margin (TTM)	90.7%	93.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-41.3%	0.0%
Net Margin (TTM)	-392.8%	0.0%
FCF Margin (TTM)	-134.4%	N/A
Net Income (TTM)	$-337M	$-32M
FCF (TTM)	$-115M	$-28M
EPS (TTM)	-$0.81	-$0.17
ROE (TTM)	-49832.0%	-3591.0%
ROA (TTM)	-9923.0%	-3334.0%
ROIC (TTM)	-12615.0%	-3591.0%
Financial Health
Cash	$16M	$138M
Debt	$94M	$0
Net Cash/Debt	$-78M	$138M
Current Ratio (TTM)	4.58x	18.83x
Quick Ratio (TTM)	3.76x	18.29x
Debt/Equity (TTM)	2.15x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	2.68
52W Performance	142.5%	503.6%
YTD Performance	82.5%	167.8%
% from 52W High	-13.0%	-26.6%
% from 52W Low	161.2%	738.1%
Efficiency & Yields
Asset Turnover (TTM)	0.54x	0.09x
FCF Yield (TTM)	-4.1%	-1.2%
Earnings Yield (TTM)	-12.1%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,740.6	0.0
EV/GP/RG	0.13	N/A
Ticker research	View PGEN research	View SLS research